Neutrophils and immunity: Challenges and opportunities

Nature Reviews Immunology

Volumn 6, Issue 3, 2006, Pages 173-182

  Nathan, Carl ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Weill Cornell Graduate School of Biomedical Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TUMOR NECROSIS FACTOR;

B LYMPHOCYTE; CELL ADHESION; CELL FATE; CELL INTERACTION; CELL SPECIFICITY; DENDRITIC CELL; HEMATOPOIESIS; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE; MEDICAL SPECIALIST; MONOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TISSUE REPAIR; WOUND HEALING;

ANIMALS; ANTIGENS, CD43; CALCIUM; HUMANS; IMMUNITY; NEUTROPHILS; PEROXIDASE; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 33344468233     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1785     Document Type: Review

References (96)

1. Nathan, C. Inflammation: points of control. Nature 420, 846-852 (2002).
2. Nathan, C. Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signalling. J. Clin. Invest 111, 769-778 (2003).
3. Henson, P. M. & Johnston, R. B. Jr. Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins. J. Clin. Invest. 79, 669-674 (1987).
4. Weiss, S. J. Tissue destruction by neutrophils. N. Engl. J. Med. 320, 365-376 (1989).
5. Lekstrom-Himes, J. A. & Gallin, J. I. Immunodeficiency diseases caused by defects in phagocytes. N. Engl. J. Med. 343, 1703-1714 (2000).
6. Klebanoff, S. J. & Clark, R. A. The Neutrophil: Function and Clinical Disorders (Elsevier/North-Holland, Amsterdam, 1978).
7. Witko-Sarsat, V., Rieu, P., Descamps-Latscha, B., Lesavre, P. & Halbwachs-Mecarelli, L. Neutrophils: molecules, functions and pathophysiological aspects. Lab. Invest. 80, 617-653 (2000).
8. Matzinger, P. The danger model: a renewed sense of self. Science 296, 301-305 (2002).
9. Medzhitov, R. & Janeway, C. A. Jr. Decoding the patterns of self and nonself by the innate immune system. Science 296, 298-300 (2002).
10. Backhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A. & Gordon, J. I. Host-bacterial mutualism in the human intestine. Science 307, 1915-1920 (2005).
11. Chertov, O. et al. Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils. J. Exp. Med. 186, 739-747 (1997).
12. Bennouna, S., Bliss, S. K., Curiel, T. J. & Denkers, E. Y. Cross-talk in the innate immune system: neutrophils instruct recruitment and activation of dendritic cells during microbial infection. J. Immunol. 171, 6052-6058 (2003).
13. Tsuda, Y. et al. Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus. Immunity 21, 215-226 (2004).
14. Wittamer, V. et al. Neutrophil-mediated maturation of chemerin: a link between innate and adaptive immunity. J. Immunol. 175, 487-493 (2005).
15. van Gisbergen, K. P., Sanchez-Hernandez, M., Geijtenbeek, T. B. & van Kooyk, Y. Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN. J. Exp. Med. 201, 1281-1292 (2005).
16. Scapini, P. et al. Proinflammatory mediators elicit secretion of the intracellular B-lymphocyte stimulator pool (BLyS) that is stored in activated neutrophils: implications for inflammatory diseases. Blood 105, 830-837 (2005).
17. Ethuin, F. et al. Human neutrophils produce interferon-γ upon stimulation by interleukin-12. Lab. Invest. 84, 1363-1371 (2004).
18. Schmielau, J. & Finn, O. J. Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients. Cancer Res. 61, 4756-4760 (2001).
19. Heissig, B. et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109, 625-637 (2002).
20. Semerad, C. L., Liu, F., Gregory, A. D., Stumpf, K. & Link, D. C. G-CSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood. Immunity 17, 413-423 (2002).
21. Stark, M. A. et al. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 22, 285-294 (2005).
22. Diefenbach, A. et al. Type 1 interferon (IFNα/β) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 8, 77-87 (1998).
23. Dovi, J. V., Szpaderska, A. M. & DiPietro, L. A. Neutrophil function in the healing wound: adding insult to injury? Thromb. Haemost. 92, 275-280 (2004).
24. Martin, P. et al. Wound healing in the PU. 1 null mouse - tissue repair is not dependent on inflammatory cells. Curr. Biol. 13, 1122-1128 (2003).
25. Singer, A. J. & Clark, R. A. Cutaneous wound healing. N. Engl. J. Med. 341, 738-746 (1999).
26. Roos, D. & Law, S. K. Hematologically important mutations: leukocyte adhesion deficiency. Blood Cells Mol. Dis. 27, 1000-1004 (2001).
27. Alon, R. & Etzioni, A. LAD-III, a novel group of leukocyte integrin activation deficiencies. Trends Immunol. 24, 561-566 (2003).
28. Nathan, C. F. Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J. Clin. Invest. 80, 1550-1560 (1987).
29. Serhan, C. N. Novel ω-3-derived local mediators in anti-inflammation and resolution. Pharmacol. Ther. 105, 7-21 (2005).
30. Jin, F. Y., Nathan, C., Radzioch, D. & Ding, A. Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 88, 417-426 (1997).
31. Zhu, J. et al. Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell 111, 867-878 (2002).
32. Grobmyer, S. R. et al. Secretory leukocyte protease inhibitor, an inhibitor of neutrophil activation, is elevated in serum in human sepsis and experimental endotoxemia. Crit. Care Med. 28, 1276-1282 (2000).
33. He, Z., Ong, C. H., Halper, J. & Bateman, A. Progranulin is a mediator of the wound response. Nature Med. 9, 225-229 (2003).
34. Klebanoff, S. J. Myeloperoxidase: friend and foe. J. Leukoc. Biol. 77, 598-625 (2005).
35. Hedrick, S. M. The acquired immune system: a vantage from beneath. Immunity 21, 607-615 (2004).
36. Casanova, J. L. & Abel, L. Inborn errors of immunity to infection: the rule rather than the exception. J. Exp. Med. 202, 197-201 (2005).
37. Nathan, C. The moving frontier in nitric oxide-dependent signalling. Sci. STKE 2 Nov 2004 (doi: 10.1126/stke. 2572004pe2572052).
38. Nathan, C. Nitric oxide as a secretory product of mammalian cells. FASEB. J. 6, 3051-3064 (1992).
39. Tonks, N. K. Redox redux: revisiting PTPs and the control of cell signalling. Cell 121, 667-670 (2005).
40. Li, Y., Karlin, A., Loike, J. D. & Silverstein, S. C. A critical concentration of neutrophils is required for effective bacterial killing in suspension. Proc. Natl Acad. Sci. USA 99, 8289-8294 (2002).
41. Savill, J. & Haslett, C. Granulocyte clearance by apoptosis in the resolution of inflammation. Semin. Cell Biol. 6, 385-393 (1995).
42. Peyssonnaux, C. et al. HIF-1 α expression regulates the bactericidal capacity of phagocytes. J. Clin. Invest. 115, 1806-1815 (2005).
43. Walmsley, S. R. et al. Hypoxia-induced neutrophil survival is mediated by HIF-1 α-dependent NF-κB activity. J. Exp. Med. 201, 105-115 (2005).
44. Jonsson, H., Allen, P. & Peng, S. L. Inflammatory arthritis requires Foxo3a to prevent Fas ligand-induced neutrophil apoptosis. Nature Med. 11, 666-671 (2005).
45. Altznauer, F. et al. Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally differentiated neutrophils. J. Exp. Med. 199, 1343-1354 (2004).
46. Flo, T. H. et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432, 917-921 (2004).
47. Brinkmann, V. et al. Neutrophil extracellular traps kill bacteria. Science 303, 1532-1535 (2004).
48. Striz, I. & Trebichavsky, I. Calprotectin- a pleiotropic molecule in acute and chronic inflammation. Physiol. Res. 53, 245-253 (2004).
49. Wright, G. W., Ooi, C. E., Weiss, J. & Elsbach, P. Purification of a cellular (granulocyte) and an extracellular (serum) phospholipase A2 that participate in the destruction of Escherichia coli in a rabbit inflammatory exudate. J. Biol. Chem. 265, 6675-6681 (1990).
50. Faurschou, M. & Borregaard, N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 5, 1317-1327 (2003).
51. Selsted, M. E. & Ouellette, A. J. Mammalian defensins in the antimicrobial immune response. Nature Immunol. 6, 551-557 (2005).
52. Weiss, J., Elsbach, P., Olsson, I. & Odeberg, H. Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J. Biol. Chem. 253, 2664-2672 (1978).
53. Campanelli, D., Detmers, P. A., Nathan, C. F. & Gabay, J. E. Azurocidin and a homologous serine protease from neutrophils. Differential antimicrobial and proteolytic properties. J. Clin. Invest. 85, 904-915 (1990).
54. Pereira, H. A., Shafer, W. M., Pohl, J., Martin, L. E. & Spitznagel, J. K. CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity. J. Clin. Invest. 85, 1468-1476 (1990).
55. McCord, J. M. & Fridovich, I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244, 6049-6055 (1969).
56. Babior, B. M., Kipnes, R. S. & Curnutte, J. T. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J. Clin. Invest. 52, 741-744 (1973).
57. Lambeth, J. D. NOX enzymes and the biology of reactive oxygen. Nature Rev. Immunol. 4, 181-189 (2004).
58. Good, R. A. et al. Fatal (chronic) granulomatous disease of childhood: a hereditary defect of leukocyte function. Semin. Hematol. 5, 215-254 (1968).
59. + flux. Nature 416, 291-297 (2002).
60. Roos, D., van Bruggen, R. & Meischl, C. Oxidative killing of microbes by neutrophils. Microbes Infect. 5, 1307-1315 (2003).
61. Shiloh, M. U. et al. Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity 10, 29-38 (1999).
62. Staudinger, B. J., Oberdoerster, M. A., Lewis, P. J. & Rosen, H. mRNA expression profiles for Escherichia coli ingested by normal and phagocyte oxidase-deficient human neutrophils. J. Clin. Invest. 110, 1151-1163 (2002).
63. Liu, G. Y. et al. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J. Exp. Med. 202, 209-215 (2005).
64. Nathan, C. F. Respiratory burst in adherent human neutrophils: triggering by colony-stimulating factors CSF-GM and CSF-G. Blood 73, 301-306 (1989).
65. Wolpe, S. D. et al. Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J. Exp. Med. 167, 570-581 (1988).
66. Nathan, C. et al. Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 integrins. J. Cell. Biol. 109, 1341-1349 (1989).
67. Nathan, C. & Sporn, M. Cytokines in context. J. Cell Biol. 113, 981-986 (1991).
68. 2-integrin CD11b/CD18 activation. Eur. J. Immunol. 29, 3419-3431 (1999).
69. Mocsai, A., Ligeti, E., Lowell, C. A. & Berton, G. Adhesion-dependent degranulation of neutrophils requires the Src family kinases Fgr and Hck. J. Immunol. 162, 1120-1126 (1999).
70. Fuortes, M., Melchior, M., Han, H., Lyon, G. J. & Nathan, C. Role of the tyrosine kinase pyk2 in the integrin-dependent activation of human neutrophils by TNF. J. Clin. Invest. 104, 327-335 (1999).
71. Mocsai, A., Zhou, M., Meng, F, Tybulewicz, V. L. & Lowell, C. A. Syk is required for integrin signalling in neutrophils. Immunity 16, 547-558 (2002).
72. Yan, S. R., Huang, M. & Berton, G. Signalling by adhesion in human neutrophils: activation of the p72syk tyrosine kinase and formation of protein complexes containing p72syk and Src family kinases in neutrophils spreading over fibrinogen. J. Immunol. 158, 1902-1910 (1997).
73. Korchak, H. M. & Kilpatrick, L. E. TNFα elicits association of PI3-kinase with the p60TNFR and activation of PI3-kinase in adherent neutrophils. Biochem. Biophys. Res. Commun. 281, 651-656 (2001).
74. Zhao, T., Benard, V., Bohl, B. P. & Bokoch, G. M. The molecular basis for adhesion-mediated suppression of reactive oxygen species generation by human neutrophils. J. Clin. Invest. 112, 1732-1740 (2003).
75. 2 integrin-dependent functions of neutrophils. J. Cell Biol. 166, 273-282 (2004).
76. Fuortes, M., Jin, W. W. & Nathan, C. Adhesion-dependent protein tyrosine phosphorylation in neutrophils treated with tumour necrosis factor. J. Cell Biol. 120, 777-784 (1993).
77. 2 integrin-dependent tyrosine phosphorylation of paxillin in human neutrophils treated with tumour necrosis factor. J. Cell Biol. 127, 1477-1483 (1994).
78. äé Jin, W. W. Albumin inhibits neutrophil spreading and hydrogen peroxide release by blocking the shedding of CD43 (sialophorin, leukosialin). J. Cell Biol. 122, 243-256 (1993).
79. Raptis, S. Z., Shapiro, S. D., Simmons, P. M., Cheng, A. M. & Pham, C. T. Serine protease cathepsin G regulates adhesion-dependent neutrophil effector functions by modulating integrin clustering. Immunity 22, 679-691 (2005).
80. 2+. Proc. Natl Acad. Sci. USA 87, 9472-9476 (1990).
81. Schumann, M. A., Gardner, P. & Raffin, T. A. Recombinant human tumour necrosis factor α induces calcium oscillation and calcium-activated chloride current in human neutrophils. The role of calcium/ calmodulin-dependent protein kinase. J. Biol. Chem. 268, 2134-2140 (1993).
82. Han, H. et al. Calcium-sensing soluble adenylyl cyclase mediates TNF signal transduction in human neutrophils. J. Exp. Med. 202, 353-361 (2005).
83. Bengtsson, T. et al. Actin dynamics in human neutrophils during adhesion and phagocytosis is controlled by changes in intracellular free calcium. Eur. J. Cell. Biol. 62, 49-58 (1993).
84. Han, H., Fuortes, M. & Nathan, C. Critical role of the carboxyl terminus of proline-rich tyrosine kinase (Pyk2) in the activation of human neutrophils by tumour necrosis factor: separation of signals for the respiratory burst and degranulation. J. Exp. Med. 197, 63-75 (2003).
85. Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860-867 (2002).
86. Rothstein, J. L. & Schreiber, H. Synergy between tumour necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice. Proc. Natl Acad. Sci. USA 85, 607-611 (1988).
87. Tepper, R. I., Pattengale, P. K. & Leder, P. Murine interleukin-4 displays potent anti-tumour activity in vivo. Cell 57, 503-512 (1989).
88. Stoppacciaro, A. et al. Regression of an established tumour genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T-cell cooperation and T cell-produced interferon γ. J. Exp. Med. 178, 151-161 (1993).
89. Soiffer, R. et al. Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumour immunity in patients with metastatic melanoma. Proc. Natl Acad. Sci. USA 95, 13141-13146 (1998).
90. Minasian, L. M. et al. Hemorrhagic tumour necrosis during a pilot trial of tumour necrosis factor-α and anti-GD3 ganglioside monoclonal antibody in patients with metastatic melanoma. Blood 83, 56-64 (1994).
91. 7 integrin. N. Engl. J. Med. 352, 2499-2507 (2005).
92. Berger, J. R. & Koralnik, I. J. Progressive multifocal leukoencephalopathy and natalizumab - unforeseen consequences. N. Engl. J. Med. 353, 414-416 (2005).
93. Langer-Gould, A., Atlas, S. W., Green, A. J., Bollen, A. W. & Pelletier, D. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N. Engl. J. Med. 353, 375-381 (2005).
94. Kleinschmidt-DeMasters, B. K. & Tyler, K. L. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon β-1 a for multiple sclerosis. N. Engl. J. Med. 353, 369-374 (2005).
95. Luisetti, M. et al. MR889, a neutrophil elastase inhibitor, in patients with chronic obstructive pulmonary disease: a double-blind, randomized, placebo-controlled clinical trial. Eur. Respir. J. 9, 1482-1486 (1996).
96. de Garavilla, L. et al. A novel, potent dual inhibitor of the leukocyte proteases cathepsin G and chymase: molecular mechanisms and anti-inflammatory activity in vivo. J. Biol. Chem. 280, 18001-18007 (2005).